This article aims to inform the reader about current knowledge of the effects of aminoglycosides on hearing. The hearing
loss caused by aminoglycosides is permanent and can negatively affect the individual’s quality of life. Although treatment with
aminoglycosides cannot be avoided in some instances, timely intervention can minimise the impact of the hearing loss on the
individual’s everyday life. The discussion includes the incidence of aminoglycoside-induced hearing loss and predisposing factors.
In addition, monitoring and management of cochlear ototoxicity is described.
This article aims to inform clinicians about the current knowledge on aminoglycoside-induced vestibulotoxicity through a review of the literature. The effects of vestibulotoxicity are irreversible and may be profoundly disabling. It would appear that the sooner vestibular rehabilitation therapy is instituted, the more favourable the prognosis is. Thus, early referral and management are essential. Vestibulotoxicity is a commonly overlooked aetiology when assessing dizzy patients. This could be due to the difficulty that patients have in describing vestibular symptoms in general, as well as the absence of vertigo as a presenting complaint. Discussion includes the clinical presentation of vestibulotoxicity and its sequelae, as well as strategies to assess and monitor patients.